Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions
Michael R. Filbin, Arnav Mehta, Alexis M. Schneider, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 5, pp. 100287-100287
Open Access | Times Cited: 238

Showing 1-25 of 238 citing articles:

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Betty Raman, David A. Bluemke, Thomas F. Lüscher, et al.
European Heart Journal (2022) Vol. 43, Iss. 11, pp. 1157-1172
Open Access | Times Cited: 536
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 576-584
Open Access | Times Cited: 458
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
Rachael A. Evans, Olivia C. Leavy, Matthew Richardson, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 8, pp. 761-775
Open Access | Times Cited: 331
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
David Ahern, Zhichao Ai, Mark Ainsworth, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 916-938.e58
Open Access | Times Cited: 265
A knowledge graph to interpret clinical proteomics data
Alberto Santos, Ana R. Colaço, Annelaura Bach Nielsen, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 5, pp. 692-702
Open Access | Times Cited: 195
Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis
Lotta Wik, Niklas Nordberg, John Broberg, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100168-100168
Open Access | Times Cited: 192
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
Clemens Gutmann, Kaloyan Takov, Sean A. Burnap, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 149
Advances and Utility of the Human Plasma Proteome
Eric W. Deutsch, Gilbert S. Omenn, Zhi Sun, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 12, pp. 5241-5263
Open Access | Times Cited: 145
Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease
Bavithra Vijayakumar, Karim Boustani, Patricia P. Ogger, et al.
Immunity (2022) Vol. 55, Iss. 3, pp. 542-556.e5
Open Access | Times Cited: 144
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Juan Dubrot, Peter P. Du, Sarah Kate Lane-Reticker, et al.
Nature Immunology (2022) Vol. 23, Iss. 10, pp. 1495-1506
Closed Access | Times Cited: 126
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes
Yijia Li, Alexis M. Schneider, Arnav Mehta, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 110
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
Sally Singh, Molly M Baldwin, Enya Daynes, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 8, pp. 709-725
Open Access | Times Cited: 95
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or‐Yam Revach, Seth Anderson, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 158-167
Open Access | Times Cited: 91
Specialized interferon action in COVID-19
Matthew D. Galbraith, Kohl T. Kinning, Kelly D. Sullivan, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 11
Open Access | Times Cited: 83
Persistent serum protein signatures define an inflammatory subcategory of long COVID
Aarthi Talla, Suhas Vasaikar, Gregory L. Szeto, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 80
A tissue injury sensing and repair pathway distinct from host pathogen defense
Siqi Liu, Yun Ha Hur, Xin Cai, et al.
Cell (2023) Vol. 186, Iss. 10, pp. 2127-2143.e22
Open Access | Times Cited: 61
NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing
Wei Feng, Joanne C. Beer, Qinyu Hao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 61
Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity
Satoshi Yoshiji, Guillaume Butler‐Laporte, Tianyuan Lu, et al.
Nature Metabolism (2023) Vol. 5, Iss. 2, pp. 248-264
Open Access | Times Cited: 53
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
Jonathan H. Chen, Linda T. Nieman, Maxwell Spurrell, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 644-658
Open Access | Times Cited: 51
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID
Manish Dhawan, Ali A. Rabaan, Sara Alwarthan, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 699-699
Open Access | Times Cited: 44
Cell–cell communication: new insights and clinical implications
Jimeng Su, Ying Song, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 40
Discovery of sparse, reliable omic biomarkers with Stabl
Julien Hédou, Ivana Marić, Grégoire Bellan, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 10, pp. 1581-1593
Open Access | Times Cited: 21
The Role of Epithelial Damage in the Pulmonary Immune Response
Rachel A. Burgoyne, Andrew J. Fisher, Lee A. Borthwick
Cells (2021) Vol. 10, Iss. 10, pp. 2763-2763
Open Access | Times Cited: 91
Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19
Daniel E. Leisman, Arnav Mehta, Bruce Thompson, et al.
American Journal of Respiratory and Critical Care Medicine (2021) Vol. 205, Iss. 5, pp. 507-519
Open Access | Times Cited: 85
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
Paulina Kapłonek, Chuangqi Wang, Yannic C. Bartsch, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 82
Page 1 - Next Page

Scroll to top